INCREASING HPV VACCINE UPTAKE

 
Pamela Hull, Ph.D., assistant professor of medicine in the division of Epidemiology and Debra Friedman, M.D., the E. Bronson Ingram Chair in Pediatric Oncology, are collaborating with Cumberland Pediatric Foundation on an NIH-funded R01 implementation study focused on increasing HPV vaccination rates among adolescents. 
 
The team will work with twenty-two CPF community-based pediatric practices in middle Tennessee to compare the clinical and cost effectiveness of two approaches to delivering quality improvement coaching focused on HPV vaccination, namely web-based versus in-person coaching. 
 
Dr. Debra Friedman says the following of the study: 
 
“This important project is a great example of population health research which is a growing national priority in Pediatrics and Oncology. Our partnership with CPF was critical to the success of the grant application. Over two years, CPF staff and practice physicians worked with us in the development of the research, pilot testing and provided incredibly valuable input. We look forward to working with CPF in implementing the research and improving the rates of HPV vaccine across Tennessee.” 
 
The Department of Pediatrics is also collaborating to provide the opportunity for participating pediatricians to receive Part IV MOC credit. 
 
For more information about the study, contact janet.l.cates@vanderbilt.edu or call 615.936.6053. 
 
 

2014-16 CPF Vaccine QI Pilot Program:

The Cumberland Pediatric Foundation is deeply committed to promoting the wellness of children and offering cost effective solutions to the CPF membership. The Vaccine Quality Improvement Program (QIP) was designed to promote the uptake of adolescent vaccines, an area where Tennessee still lags behind national benchmarks.  According to the CDC, every year we delay increasing HPV vaccination rates up to 80 percent. Another 4,400 girls will develop cervical cancer each year.  Those numbers do not include the impact of HPV in oral cancers in males. Over the past two years, CPF has partnered with Metro Nashville Public Schools, Alignment Nashville, TENNderCARE, the Vanderbilt Ingram Cancer Center, Cervical Cancer Free Tennessee Coalition and the State of Tennessee’s Immunization Program. Together we have worked on a variety of initiatives related to improving the awareness and the uptake of adolescent vaccines.

The Vaccine Quality Improvement Program is a pilot program created internally by CPF and was open for participation to CPF members through December 31, 2014. The three vaccines being evaluated in the QIP pilot phase are TdaP, Meningococcal and HPV. The data collection portion of the program will end August 31, 2015.  Each of the 19 participating practices will be eligible to receive payments for each participating physician once baseline data and 2015 comparative data are submitted.

The baseline data submission includes TdaP and HPV vaccination rates for all 13 year olds, male and female, and for all patients between the ages of 16 and 18 who received the Meningococcal booster in FY 2012-13.To date, 15 practices have received compensation for reporting their baseline data. CPF will use this data to establish baseline rates for comparison, and it will be used to inform the preparation of a grant proposal in which CPF will collaborate with the Vanderbilt-Ingram Cancer Center (VICC) and Cervical Cancer Free Tennessee to promote HPV uptake to prevent cancer as part of the adolescent vaccine platform. All practice data will be de-identified. See current rates here

CPF is providing educational opportunities for participating practices to increase their adolescent vaccine rates. The CPF Annual Meeting featured a panel focused on HPV vaccine for cancer prevention and a new CME has been developed, both in collaboration with VICC and the Tennessee Immunization Program. CPF is also partnering with the Meharry-Vanderbilt-TSU Cancer Partnership in the use of their social marketing campaign called Bug Your Doc - Get 3 Shots aimed at educating parents to obtain TdaP, meningitis, and HPV vaccines for their children at age 11 and 12. Click here to read more in a recent VICC Momentum article.

The second part of the project will involve the collection of data through August 31, 2015. CPF will use the data from this time period to assess whether or not the adolescent vaccination rates have improved in these practices since signing up for the program.  Practices will be compensated in 2015 for each participating physician if they reach certain benchmarks which are outlined in the study details. The amount of payment from CPF to the practice for this work could be as much as $450 per physician!

CPF Quality Improvement Plan Program Guidelines

In addition to offering payments, CPF is complementing this effort with educational programs to support vaccine uptake in the participating practices.

A special thanks to those who have partnered with CPF in this endeavor.

Presentation Title: Cancer Prevention Starts in Childhood: Vaccine in Pre-teen
Moderator: Robert Lillard MD, FAAP, CPF Medical Director
Debra Friedman MD, MS 
C. Buddy Creech, MD, MPH
Kelly L. Moore, MD, MPH
Scott Hiebert, PhD
Pam Hull, PhD

Buddy Creech, MD, MPH
Video: Basics of Vaccine

Kelly Moore, MD, MPH - HPV Cancer Prevention 

Vaccine and Cancer Prevention (Presented at TMA MedTenn 2015 Conference)
Moderator: Robert Lillard MD, FAAP, CPF Medical Director
Debra Friedman MD, MS 
Sarah Elizabeth WIlliams, MD
Kelly L. Moore, MD, MPH
Scott Hiebert, PhD
Pam Hull, PhD

Debra Friedman, MD
E. Bronson Ingram Chair in Pediatric Oncology
Associate Professor of Pediatrics
Leader, Vanderbilt-Ingram Cancer Center Cancer Control and Prevention Program
Director, Division of Hematology-Oncology) 
HPV Vaccine & Cancer Prevention | CME: July 15, 2014 (Co-presented with Pam Hull, PhD)
Why Did My Child Get Cancer? | CME: May 12, 2015 

Cervical Cancer Free Tennessee 

Vanderbilt HPV workgroup 

State of Tennessee Immunization Program (TWIS)